<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39179487</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0305</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Aug</Month><Day>14</Day></PubDate></JournalIssue><Title>Cytokine &amp; growth factor reviews</Title><ISOAbbreviation>Cytokine Growth Factor Rev</ISOAbbreviation></Journal><ArticleTitle>The intersection of microbiome and autoimmunity in long COVID-19: Current insights and future directions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1359-6101(24)00062-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cytogfr.2024.08.002</ELocationID><Abstract><AbstractText>Long COVID-19 affects a significant percentage of patients and is characterized by a wide range of symptoms, including weariness and mental fog as well as emotional symptoms like worry and sadness. COVID-19 is closely linked to the autoimmune disorders that are becoming more prevalent worldwide and are linked to immune system hyperactivation, neutrophil extracellular trap (NET) development, and molecular mimicry pathways. Long-term COVID-related autoimmune responses include a watchful immune system referring to the ability of immune system to constantly monitor the body for signs of infection, disease, or abnormal cells; altered innate and adaptive immune cells, autoantigens secreted by living or dead neutrophils, and high concentrations of autoantibodies directed against different proteins. The microbiome, which consists of billions of bacteria living in the human body, is essential for controlling immune responses and supporting overall health. The microbiome can affect the course of long COVID-associated autoimmunity, including the degree of illness, the rate of recovery, and the onset of autoimmune reactions. Although the precise role of the microbiome in long COVID autoimmunity is still being investigated, new studies indicate that probiotics, prebiotics, and dietary changes-interventions that target the microbiome-may be able to reduce autoimmune reactions and enhance long-term outcomes for COVID-19 survivors. More research is required to precisely understand how the microbiome affects COVID-19-related autoimmunity and to create tailored treatment plans.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hromi&#x107;-Jahjefendi&#x107;</LastName><ForeName>Altijana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, International University of Sarajevo,&#xa0;Hrasnicka cesta 15,&#xa0;Sarajevo 71000,&#xa0;Bosnia and Herzegovina. Electronic address: ahromic@ius.edu.ba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmutovi&#x107;</LastName><ForeName>Lejla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, International University of Sarajevo,&#xa0;Hrasnicka cesta 15,&#xa0;Sarajevo 71000,&#xa0;Bosnia and Herzegovina. Electronic address: lhalilovic@ius.edu.ba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sezer</LastName><ForeName>Abas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, International University of Sarajevo,&#xa0;Hrasnicka cesta 15,&#xa0;Sarajevo 71000,&#xa0;Bosnia and Herzegovina. Electronic address: asezer@ius.edu.ba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Be&#x107;irevi&#x107;</LastName><ForeName>Tea</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Atrijum Polyclinic,&#xa0;Sarajevo,&#xa0;Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubio-Casillas</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Autlan Regional Hospital, Health Secretariat,&#xa0;Autlan,&#xa0;Jalisco 48900,&#xa0;Mexico; Biology Laboratory, Autlan Regional Preparatory School, University of Guadalajara,&#xa0;Autlan,&#xa0;Jalisco 48900,&#xa0;Mexico. Electronic address: alberto.rubio@sems.udg.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redwan</LastName><ForeName>Elrashdy M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Therapeutic and Protective Proteins Laboratory, Protein Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, New Borg EL-Arab 21934, Alexandria, Egypt. Electronic address: lradwan@kau.edu.sa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uversky</LastName><ForeName>Vladimir N</ForeName><Initials>VN</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida,&#xa0;12901 Bruce B. Downs Blvd.,&#xa0;MDC07,&#xa0;Tampa,&#xa0;FL,&#xa0;USA. Electronic address: vuversky@usf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cytokine Growth Factor Rev</MedlineTA><NlmUniqueID>9612306</NlmUniqueID><ISSNLinking>1359-6101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">Autoantibodies</Keyword><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Microbiome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>21</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39179487</ArticleId><ArticleId IdType="doi">10.1016/j.cytogfr.2024.08.002</ArticleId><ArticleId IdType="pii">S1359-6101(24)00062-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>